Zevra Therapeutics, Inc.
ZVRA
$9.28
-$0.05-0.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.81% | 2.60% | 7.13% | -43.62% | -44.67% |
| Total Receivables | 51.92% | -39.52% | -85.00% | -36.24% | 6.17% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 101.61% | 122.15% | 37.03% | 32.77% | 59.11% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 29.71% | -1.05% | -27.42% | -41.13% | -39.69% |
|
|
|||||
| Total Current Assets | 29.71% | -1.05% | -27.42% | -41.13% | -39.69% |
| Net Property, Plant & Equipment | 15.55% | -33.62% | 6.49% | 6.50% | 8.47% |
| Long-term Investments | 0.00% | 0.00% | -- | -- | -- |
| Goodwill | 0.00% | 0.00% | -- | -- | -- |
| Total Other Intangibles | -0.48% | -0.34% | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -23.25% | 14.57% | 1,373.45% | 1,748.58% | 2,011.74% |
| Total Assets | 14.16% | 3.37% | 37.82% | 36.86% | 41.92% |
|
|
|||||
| Total Accounts Payable | -21.80% | -6.52% | 105.93% | 94.60% | 150.44% |
| Total Accrued Expenses | 16.06% | -8.42% | -5.97% | -2.83% | -22.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.03% | -22.65% | 24.14% | 29.85% | 22.74% |
| Total Finance Division Other Current Liabilities | 62.81% | 26.78% | 200.97% | 727.99% | 603.37% |
| Total Other Current Liabilities | 62.81% | 26.78% | 200.97% | 727.99% | 603.37% |
| Total Current Liabilities | -9.81% | -53.79% | 58.80% | 66.83% | 91.53% |
|
|
|||||
| Total Current Liabilities | -9.81% | -53.79% | 58.80% | 66.83% | 91.53% |
| Long-Term Debt | 39.75% | 1,074.58% | 34.26% | 358.95% | 232.96% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 64.26% | -18.42% | -6.58% | -13.24% | -4.21% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 50.63% | 42.60% | 416.24% | 316.30% | 386.97% |
| Total Liabilities | 28.52% | 25.35% | 70.29% | 202.36% | 191.17% |
|
|
|||||
| Common Stock & APIC | 17.73% | 17.48% | 31.63% | 18.32% | 18.19% |
| Retained Earnings | -22.09% | -26.39% | -38.32% | -34.08% | -29.99% |
| Treasury Stock & Other | -2.06% | 6.11% | 0.94% | 5.76% | 1.85% |
| Total Common Equity | -15.97% | -35.88% | 3.41% | -52.59% | -31.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -15.97% | -35.88% | 3.41% | -52.59% | -31.63% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -15.97% | -35.88% | 3.41% | -52.59% | -31.63% |
|
|
|||||